Kidney failure · preventing the progression of CKD
It is very uncertain whether metformin changes kidney failure (median compared with placebo (very low certainty).
1 finding from 1 review
Change in proteinuria (1 year) · preventing the progression of CKD
1 finding from 1 review
Change in eGFR · preventing the progression of CKD
1 finding from 1 review
All‐cause death ( · preventing the progression of CKD
Metformin showed no clear difference in all‐cause death ( compared with active control (low certainty).
1 finding from 1 review
Symptomatic, culture‐verified UTI Women with recurrent UTI · preventing UTI
Any cranberry product probably leads to lower symptomatic, culture‐verified UTI Women with recurrent UTI compared with placebo or control (moderate certainty).
1 finding from 1 review
Symptomatic, culture‐verified UTI Elderly men and women in institutions · preventing UTI
Any cranberry product showed no clear difference in symptomatic, culture‐verified UTI Elderly men and women in… compared with placebo or control (moderate certainty).
1 finding from 1 review
Symptomatic, culture‐verified UTI Children · preventing UTI
Any cranberry product probably leads to lower symptomatic, culture‐verified UTI Children compared with placebo or control (moderate certainty).
1 finding from 1 review
Symptomatic, culture‐verified UTI Adults with bladder emptying issues or multiple sclerosis · preventing UTI
Any cranberry product showed no clear difference in symptomatic, culture‐verified UTI Adults with bladder emptying… compared with placebo or control (low certainty).
1 finding from 1 review
Symptomatic, culture‐verified UTI People with a susceptibility to a UTI due to an intervention · preventing UTI
Any cranberry product may leads to lower symptomatic, culture‐verified UTI People with a susceptibility to a… compared with placebo or control (low certainty).
1 finding from 1 review
Gastrointestinal adverse events · preventing UTI
Any cranberry product showed no clear difference in gastrointestinal adverse events compared with placebo or control (moderate certainty).
1 finding from 1 review
Indoxyl sulfate · people with CKD
1 finding from 1 review
Change in any GI upset (borborygmi) · people with CKD
It is very uncertain whether synbiotic changes change in any GI upset (borborygmi) compared with prebiotic (very low certainty).
1 finding from 1 review
Change in any GI upset (GSRS total index) · people with CKD
1 finding from 1 review
Microbiota composition · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Graft function · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Graft infection · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
eGFR · people with CKD
1 finding from 1 review
Albuminuria or proteinuria · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Symptomatic, culture‐verified UTI Women with recurrent UTI · women with acute cystitis or history of recurrent acute cystitis (preventing and treating)
It is very uncertain whether D‐mannose (2 g) changes symptomatic and bacteriuria confirmed UTI (positive culture) compared with no treatment (very low certainty).
1 finding from 1 review
Asymptomatic bacteriuria · women with acute cystitis or history of recurrent acute cystitis (preventing and treating)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found